Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.

CA 242, a novel tumour carbohydrate antigen present in serum (upper limit of normal values: 20.0 U ml-1), has been measured in a group of 102 pathologically confirmed non-small cell lung cancer patients. The aim of the present prospective study was to identify any relationship between pre-treatment...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Pujol, J. L., Cooper, E. H., Lehmann, M., Purves, D. A., Dan-Aouta, M., Midander, J., Godard, P., Michel, F. B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 1993
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968478/
https://ncbi.nlm.nih.gov/pubmed/8390291
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia